Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04080011 · ClinicalTrials.gov registry record · NA

A Case Series Study of Negative Pressure Platform Wound Device

A NA study of Incisions, Surgical, sponsored by The Metis Foundation.

Completed
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT04080011: Completed NA study of Incisions, Surgical, sponsored by The Metis Foundation.

NCT04080011 is a NA study of Incisions, Surgical that has completed, run by The Metis Foundation. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04080011, a NA study of Incisions, Surgical, has completed, sponsored by The Metis Foundation.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

This primary case series study will demonstrate the safety and feasibility of the NP-PWD technology and treatment protocol to promote healing of surgical incision healing. In a first use in humans of the NP-PWD's capability to deliver negative pressure wound treatment (NPWT), this project will gather data from patients with elective surgical incisions, with the intention to evaluate the NPWT capability for future use in more tenuous situations of wound closure.

Primary Outcome

Safety is assessed by recording each adverse event (AE) occurring during the period the patient has the study device applied and throughout the entire enrollment period.

Conditions Studied

Interventions

  • DEVICE NP-PWD

Study Locations (1)

Texas

  • Northeast Baptist - San Antonio

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2019-08-30
Est. Completion 2019-12-11
Phase NA
The Metis Foundation

8 total trials

What the finished NCT04080011 record still lists

NCT04080011 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Incisions, Surgical appearing as the primary indexed condition, and to 1 intervention - of which NP-PWD is the first listed.

NCT04080011 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT04080011 about?

NCT04080011 is a clinical study titled "A Case Series Study of Negative Pressure Platform Wound Device". This primary case series study will demonstrate the safety and feasibility of the NP-PWD technology and treatment protocol to promote healing of surgical incision healing. In a first use in humans of the NP-PWD's capability to deliver negative pressure wound treatment (NPWT), this project will gathe...

What is the current status of trial NCT04080011?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2019-08-30. Estimated completion is 2019-12-11.

What conditions does trial NCT04080011 study?

This clinical trial studies the following conditions: Incisions, Surgical.

What interventions are being tested in trial NCT04080011?

The interventions under investigation include: NP-PWD (DEVICE).

Who is sponsoring clinical trial NCT04080011?

This trial is sponsored by The Metis Foundation, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04080011 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT04080011's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04080011, the US trial registry maintained by the National Library of Medicine. NCT04080011 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.